PTC India Financial Services Ltd., incorporated in the year 2006, is a Small Cap company (having a market cap of Rs 2,167.71 Crore) operating in Term Lending Institutions sector. PTC India Financial ...

In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...

PTC Industries (PTCIL)’s Q2FY26 EBITDA recovered to INR 257mn (+21% YoY), after a dismal Q1, as we believe TARC EBITDA losses would have reduced and ATL performance has improved. EBITDA margin, at ...

PTC is selling off its IoT businesses, Kepware and ThingWorx, in order to hone its focus on SaaS and AI, according to CEO Neil Barua, as the conglomerate announced a sale of the operations to asset ...

Shares of PTC Industries rallied 5 per cent to ₹17,900 on the BSE in Monday’s intra-day trade after the company said it received a Purchase Order from Gas Turbine Research Establishment (GTRE), ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. PTC Therapeutics, Inc. is one of them. PTC Therapeutics, Inc. (NASDAQ:PTCT) is reinforcing its ...

PTC has evolved into an SaaS-driven industrial software leader with improved profitability, higher margins, and a stronger competitive moat. Growth has been heavily acquisition-driven, raising ...

PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) after a phase 3 fail in 2023. Despite its efforts, the FDA has snubbed the ...

PTC has announced a major expansion of its collaboration with Nvidia, integrating the computing company’s Omniverse technologies into its flagship Creo and Windchill platforms. The move, PTC said, ...